Abstract
Background: Lamivudine was approved by Food and Drug Administration of the United States for the treatment of both HIV and HBV infection, which has been widely used as monotherapy or a component of combination therapy in clinics in many countries and nationalities.
Methods: In this paper, the recent chromatographic and mass spectrometry analytical methods for the determination of lamivudine individually or combination with other drugs simultaneously were presented. These methods were widely applied in pharmacokinetics studies, bioequivalence studies, therapeutic drug monitoring studies, cell and animal experiments.
Conclusion: The review paper might provide references for determining lamivudine in biological fluids, the intracorporal process of lamivudine, and the clinical practice by monitoring plasma concentration of lamivudine in the future.
Keywords: Lamivudine, biological fluids, chromatographic analysis, mass spectrometry analysis, HPLC, nucleoside ring.
Graphical Abstract
[1]
Leung, N. Lamivudine for chronic hepatitis B. Expert Rev. Anti Infect. Ther., 2004, 2(2), 173-180.
[2]
Kumar, P.N.; Patel, P. Lamivudine for the treatment of HIV. Expert Opin. Drug Metab. Toxicol., 2010, 6(1), 105-114.
[3]
Siddiqui, M.R.; AlOthman, Z.A.; Rahman, N. Analytical techniques in pharmaceutical analysis: A review. Arab. J. Chem., 2017, 10, S1409-S1421.
[4]
Rahman, N.; Azmi, S.N.H.; Wu, H-F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit. Qual. Assur., 2006, 11, 69-74.
[5]
Alothman, Z.A.; Rahman, N.; Siddiqui, M.R. Review on pharmaceutical impurities, stability studies and degradation products: An analytical approach. Rev. Adv. Sci. Engin., 2013, 2(2), 155-166.
[6]
Ye, M.; Wang, L.; Fu, Q.; Zhu, Z.; Li, P.; Li, T. Steady-state pharmacokinetics of lamivudine once-daily versus twice-daily dosing in Chinese HIV-infected patients. HIV Clin. Trials, 2010, 11(4), 230-237.
[7]
Wattananat, T.; Prasanchaimontri, I.O.; Akarawut, W. Simultaneous determination of stavudine and lamivudine in human plasma by high performance liquid chromatography and its application to a bioavailability study. Southeast Asian J. Trop. Med. Public Health, 2010, 41(2), 369-377.
[8]
Bouazza, N.; Hirt, D.; Blanche, S.; Frange, P.; Rey, E.; Treluyer, J.M.; Urien, S. Developmental pharmacokinetics of lamivudine in 580 pediatric patients ranging from neonates to adolescents. Antimicrob. Agents Chemother., 2011, 55(7), 3498-3504.
[9]
Nandi, U.; Das, A.; Roy, B.; Choudhury, H.; Gorain, B.; Pal, T.K. Development and validation of an HPLC-UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteers. Drug Test. Anal., 2013, 5(6), 485-491.
[10]
Esseku, F.; Joshi, A.; Oyegbile, Y.; Edowhorhu, G.; Gbadero, D.; Adeyeye, M. A randomized pahse I bioequivalence clinincal trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers. Antivir. Ther., 2013, 18(2), 205-212.
[11]
Dezani, A.B.; Pereira, T.M.; Caffaro, A.M.; Reis, J.M.; Serra, C.H. Determination of lamivudine and zidovudine permeability using a different ex vivo method in Franz cells. J. Pharmacol. Toxicol. Methods, 2013, 67(3), 194-202.
[12]
Alebouyeh, M.; Amini, H. Rapid determination of lamivudine in human plasma by high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2015, 975, 40-44.
[13]
Yadav, M.; Singhal, P.; Goswami, S.; Pande, U.C.; Sanyal, M.; Shrivastav, P.S. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects. J. Chromatogr. Sci., 2010, 48(9), 704-713.
[14]
Li, Z.; Ding, C.; Ge, Q.; Zhou, Z.; Zhi, X.; Liu, X. Simultaneous determination of lamivudine, stavudine and nevirapine in human plasma by LC-MS/MS and its application to pharmacokinetic study in clinic. Biomed. Chromatogr., 2010, 24(9), 926-934.
[15]
Nirogi, R.; Kandikere, V.; Komarneni, P.; Aleti, R.; Padala, N.; Kalaikadhiban, I.; Bhyrapuneni, G.; Muddana, N. Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study. Biomed. Chromatogr., 2012, 26(12), 1472-1481.
[16]
Else, L.J.; Jackson, A.; Puls, R.; Hill, A.; Fahey, P.; Lin, E.; Amara, A.; Siccardi, M.; Watson, V.; Tjia, J.; Emery, S.; Khoo, S.; Back, D.J.; Boffito, M. Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study. Antimicrob. Agents Chemother., 2012, 56(3), 1427-1433.
[17]
Matta, M.K.; Burugula, L.; Pilli, N.R.; Inamadugu, J.K. J, V.L.N.S. A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr., 2012, 26(10), 1202-1209.
[18]
Rower, J.E.; Klein, B.; Bushman, L.R.; Anderson, P.L. Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasma. Biomed. Chromatogr., 2012, 26(1), 12-20.
[19]
Notari, S.; Sergi, M.; Montesano, C.; Ivanovic, J.; Narciso, P.; Pucillo, L.P.; Ascenzi, P. Simultaneous determination of lamivudine, lopinavir, ritonavir, and zidovudine concentration in plasma of HIV-infected patients by HPLC-MS/MS. IUBMB Life, 2012, 64(5), 443-449.
[20]
Valluru, R.K. B, P.B.; S, K.S.; V, P.K.; Kilaru, N.B. High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 931, 117-126.
[21]
Fok, B.S.; Gardner, S.; Piscitelli, S.; Chen, S.; Chu, T.T.; Chan, J.C.; Tomlinson, B. Pharmacokinetic properties of single-dose lamivudine/adefovir dipivoxil fixed-dose combination in healthy Chinese male volunteers. Clin. Ther., 2013, 35(1), 68-76.
[22]
Kumar, V.R.; Reddy, B.P.; Kumar, B.R.; Sreekanth, K.; Babu, K.N. High throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 921-922, 9-14.
[23]
Kromdijk, W.; Pereira, S.A.; Rosing, H.; Mulder, J.W.; Beijnen, J.H.; Huitema, A.D. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 919-920, 43-51.
[24]
Mistri, H.N.; Jangid, A.G.; Pudage, A.; Gomes, N.; Sanyal, M.; Shrivastav, P. High throughput LC-MS/MS method for simultaneous quantification of lamivudine, stavudine and nevirapine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2007, 853(1-2), 320-332.
[25]
Gehrig, A.K.; Mikus, G.; Haefeli, W.E.; Burhenne, J. Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma. Rapid Commun. Mass Spectrom., 2007, 21(16), 2704-2716.
Article Metrics
47
4